Last modification: 2011/08/22

Autor(en) Titel Quelle Links
Gaartman AE, Sayedi AK, Gerritsma JJ, de Back TR, van Tuijn CF, Tang MW, Heijboer H, de Heer K, Biemond BJ, Nur E Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors. British journal of haematology 2021, Online ahead of print    
Gaab C, Adolph JE, Tippelt S, Mikasch R, Obrecht D, Mynarek M, Rutkowski S, Pfister SM, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Sträter R, Bode U, Faldum A, Kwiecien R, Fleischhack G Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study. Cancers 2022, 14    
Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994, 23: 72    
Gadner H, Ladisch S, Arico M, Broadbent V, Jakobson A, Komp D, Nicholson S VP-16 and the treatment of histiocytosis. Eur J Pediatr 1994, 153: 389    
Gadner H Etoposide in Langerhans cell histiocytosis. Pediatr Hematol Oncol 1996, 13: 309    
Gadner H Therapie von Leukämien, Lymphomen, Soliden Tumoren, Spezielle Therapiemodalitäten, Regionale Chemotherapie, Notfälle. Langerhans-Zell-Histiozytose in Kompendium Internistische Onkologie 1999, 2294    
Gadner H Langerhans' cell histiocytosis - still an unsolved problem editorial. Pediatr Hematol Oncol 1999, 16: 489    
Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, Komp D, Michaelis J, Nicholson S, Potschger U, Pritchard J, Ladisch S A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001, 138: 728    
Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, Komp D, Michaelis J, Nicholson S, Pötschger U, Pritchard J, Ladisch S, Histiocyte Society A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. The Journal of pediatrics 2001, 138: 728    
Gadner H, Haas O, Masera G, Pui C, Schrappe M Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2003, 17: 798    
Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg) Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006    
Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S Therapy prolongation improves outcome in multi-system Langerhans cell histiocytosis. Blood 2013, Epub ahead of print    
Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, Langston JW, Muhlbauer M, Boyett JM, Kun LE Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997, 15: 2792    
Gajjar A, Kühl J, Epelman S, Bailey C, Allen J Chemotherapy of medulloblastoma. Childs Nerv Syst 1999, 15: 554    
Gallie BL, Dunn JM, Chan HS, Hamel PA, Phillips RA The genetics of retinoblastoma. Relevance to the patient. Pediatric clinics of North America 1991, 38: 299    
Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood 2002, 100: 2732    
Ganz T, Nemeth E Iron sequestration and anemia of inflammation. Semin hematol 2009, 46: 387    
Ganz T Iron and infection. International journal of hematology 2018, 107: 7    
Garre M, El-Hossainy M, Fondelli P, Göbel U, Brisigotti M, Donati P, Nantron M, Ravegnani M, Garaventa A, De Bernardi B Is chemotherapy effective therapy for intracranial immature teratoma? Cancer 1996, 77: 977    
Garde S, Knaup P, Herold R Remodeling of Legacy Systems in Health Care using UML. Stud Health Technol Inform 2002, 90: 478    
Garde S, Baumgarten B, Basu O, Graf N, Haux R, Herold R, Kutscha U, Schilling F, Selle B, Spiess C, Wetter T, Knaup P A Meta-Model of Chemotherapy Planning in the Multi-Hospital / Multi-Trial-Center-Environment of Pediatric Oncology. Methods of Information in Medicine 2004, 43: 171    
Garbe E, Andersohn F, Bronder E, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Mayer B, Salama A, Kurtal H Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. British journal of haematology 2011, 154: 644    
Garcia-Puig M, Fons-Estupina MC, Rives-Sola S, Berrueco-Moreno R, Cruz-Martinez O, Campistol J [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings]. Revista de neurologia 2012 Jun 16; 54: 712    
Garçon L, Ge J, Manjunath SH, Mills JA, Apicella M, Parikh S, Sullivan LM, Podsakoff GM, Gadue P, French DL, Mason PJ, Bessler M, Weiss MJ Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 2013, 122: 912    
Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Jürgens H, Oberlin O Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Sep 20; 33: 3036    
Gastberger K, Fincke VE, Mucha M, Siebert R, Hasselblatt M, Frühwald MC Current Molecular and Clinical Landscape of ATRT - The Link to Future Therapies. Cancer management and research 2023, 15: 1369    
Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M, EUROCARE Working Group Childhood cancer survival trends in Europe: a EUROCARE Working Group study. Journal of clinical oncology 2005, 23: 3742    
Gauß G, Beller R, Boos J, Däggelmann J, Stalf H, Wiskemann J, Götte M Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey. Frontiers in pediatrics 2021, 9: 682496    
Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, Ness KK A systematic review of dental late effects in survivors of childhood cancer. Pediatric blood & cancer 2014, 61: 407    
Gazda H, Lipton JM, Willig TN, Ball S, Niemeyer CM, Tchernia G, Mohandas N, Daly MJ, Ploszynska A, Orfali KA, Vlachos A, Glader BE, Rokicka-Milewska R, Ohara A, Baker D, Pospisilova D, Webber A, Viskochil DH, Nathan DG, Beggs AH, Sieff CA Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23. 3-p22 and for non-19q non-8p disease. Blood 2001, 97: 2145    
Gazda, HT, Zhong R, Long L, Niewiadomska E, Lipton, JM, Ploszynska A, Zaucha, JM, Vlachos A, Atsidaftos E, Viskochil, DH, Niemeyer, CM, Meerpohl, JJ, Rokicka-Milewska R, Pospisilova D, Wiktor-Jedrzejczak W, Nathan, DG, Beggs, AH, Sieff, CA RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol 2004, 127: 105    
Gazda, HT, Grabowska A, Merida-Long, LB, Latawiec E, Schneider, HE, Lipton, JM, Vlachos A, Atsidaftos E, Ball, SE, Orfali, KA, Niewiadomska E, Da Costa L, Tchernia G, Niemeyer C, Meerpohl, JJ, Stahl J, Schratt G, Glader B, Backer K, Wong C, Nathan, DG, Beggs, AH, Sieff, CA Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am.J Hum.Genet 2006, 79: 1110-8. Epub 2006 Nov 2.    
Gemeinsamer Bundesausschuss Richtlinien zur Kinderonkologie. Stand 01/2023 aufgerufen am 6.12.2023    
Gebert C, Brinkschmidt C, Bielack S, Bernhardt T, Jürgens H, Böcker W, Winkelmann W, Bürger H, Gosheger, G The potential of comparative genomic hybridization as a tool in the differential diagnosis of matrix-producing bone lesions. Int J Surg Pathol 2006, 14: 187    
Gebauer J, Baust K, Bardi E, Grabow D, Stein A, van der Pal HJ, Calaminus G, Langer T Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work. Oncology research and treatment 2020, 43: 61    
Gehring M, Berthold F, Schwab M, Amler L Genetic stability of microsatellites in human neuroblastomas. J Clin Oncol 1994, 4: 1043    
Gehring M, Berthold F, Edler L, Schwab M, Amler L The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 1995, 55: 5366    
George JN, Shattil SJ The clinical importance of acquired abnormalities of platelet function. The New England journal of medicine 1991 Jan 3; 324: 27    
Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F Metabolic activity and clinical features of primary ganglioneuromas. Cancer 2001, 91: 1905    
George JN, Vesely SK Immune thrombocytopenic purpura--let the treatment fit the patient. The New England journal of medicine 2003, 349: 903    
George JN Children with ITP: Looking beyond the platelet count. Pediatric blood & cancer 2012, 58: 323    
Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Fosså A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Körholz D, Sabri O, Mauz-Körholz C 18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required? Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018, 59: 1524    
Gerhardt T, Schmahl G, Flotho C, Rath A, Niemeyer C Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors. Br J Haematol 1997, 99: 882    
Gerres L, Brämswig J, Schlegel W, Jürgens H, Schellong G The effects of etoposide on testicular function in boys treated for Hodgkin's disease. Cancer 1998, 83: 2217    
Gerth HU, Rompel A, Krebs B, Boos J, Lanvers-Kaminsky C Cytotoxic effects of novel polyoxotungstates and a platinum compound on human cancer cell lines. Anti-cancer drugs 2005, 16: 101    
Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007, 48: 1932    
Germeshausen M, Skokowa J, Ballmaier M, Zeidler C, Welte K G-CSF receptor mutations in patients with congenital neutropenia. Current opinion in hematology 2008, 15: 332    
Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, Sposto R, McCarthy K, Lacombe MJ, Perkins SL, Patte C, FAB LMB96 International Study Committee Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. British journal of haematology 2008, 141: 840    
Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Annals of hematology 2008, 87: 691    
Gerr H, Zimmermann M, Schrappe M, Dworzak M, Ludwig WD, Bradtke J, Moericke A, Schabath R, Creutzig U, Reinhardt D Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. British journal of haematology 2010, 149: 84    
Gerber A, Rossi R Neonatologische Versorgung – Fallzahlregelung Einfluss auf Qualität und Finanzierung pädiatrischer Einrichtungen. Monatsschr Kinderheilkd 2010 158: 356–363    
Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Warmuth-Metz M, Pietsch T, Soerensen N, Faldum A, Emser A, Schlegel PG, Deinlein F, Kortmann RD, Rutkowski S Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. J Neurooncol 2011, 102: 459    
Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Deinlein F, Benesch M, Zwiener I, Soerensen N, Warmuth-Metz M, Pietsch T, Mittler U, Kuehl J, Kortmann RD, Grotzer MA, Rutkowski S A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. European journal of cancer 2011, [Epub ahead of print]    
Gerber NU, von Hoff K, Resch A, Ottensmeier H, Kwiecien R, Faldum A, Matuschek C, Hornung D, Bremer M, Benesch M, Pietsch T, Warmuth-Metz M, Kuehl J, Rutkowski S, Kortmann RD Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. International journal of radiation oncology, biology, physics 2014, 89: 863    
Gerber NU, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S Recent developments and current concepts in medulloblastoma. Cancer treatment reviews 2014, 40: 356    
Gerstl L, Heinen F, Borggraefe I, Olivieri M, Kurnik K, Nicolai T, Reiter K, Berweck S, Schröder AS Pädiatrischer Schlaganfall – ein kinderneurologischer Notfall. Klinik, Diagnostik und Therapie. Monatsschr Kinderheilkd 2017, 5    
Gerrand C, Bate J, Seddon B, Dirksen U, Randall RL, van de Sande M, O'Donnell P, Tuckett J, Peake D, Jeys L, Saifuddin A, Grainger M, Whelan J Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma. Clinical sarcoma research 2020, 10: 21    
Gessi M, von Bueren AO, Treszl A, Mühlen AZ, Hartmann W, Warmuth-Metz M, Rutkowski S, Pietsch T MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system. Neuro-oncology 2014,    
Gessi M, Capper D, Sahm F, Huang K, von Deimling A, Tippelt S, Fleischhack G, Scherbaum D, Alfer J, Juhnke BO, von Hoff K, Rutkowski S, Warmuth-Metz M, Chavez L, Pfister SM, Pietsch T, Jones DT, Sturm D Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta neuropathologica 2016, 132: 635    
Gessler M, Graf N Less may be more for stage I epithelial Wilms tumors. Cancer 2020, 126: 2762    
Geyer JR, Finlay JL, Boyett JM, Wisoff J, Yates A, Mao L, Packer RJ Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer 1995, 75: 1045    
Ghosh MC, Zhang DL, Ollivierre WH, Noguchi A, Springer DA, Linehan WM, Rouault TA Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases. Blood 2021, 137: 2509    
Giampietro PF, Adler-Brecher B, Verlander PC, Pavlakis SG, Davis JG, Auerbach AD The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics 1993, 91: 1116    
Giardino S, de Latour RP, Aljurf M, Eikema DJ, Bosman P, Bertrand Y, Tbakhi A, Holter W, Bornhäuser M, Rössig C, Burkhardt B, Zecca M, Afanasyev B, Michel G, Ganser A, Alseraihy A, Ayas M, Uckan-Cetinkaya D, Bruno B, Patrick K, Bader P, Itälä-Remes M, Rocha V, Jubert C, Diaz MA, Shaw PJ, Junior LGD, Locatelli F, Kröger N, Faraci M, Pierri F, Lanino E, Miano M, Risitano A, Robin M, Dufour C, Severe Aplastic Anemia and Chronic Malignancies Working Parties of European Blood and Marrow Transplantation group Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group. American journal of hematology 2020, 95: 809    
Gianferante MD, Wlodarski MW, Atsidaftos E, Da Costa L, Delaporta P, Farrar JE, Goldman FD, Hussain M, Kattamis A, Leblanc T, Lipton JM, Niemeyer CM, Pospisilova D, Quarello P, Ramenghi U, Sankaran VG, Vlachos A, Volejnikova J, Alter BP, Savage SA, Giri N Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A. Haematologica 2021, 106: 1303    
Gialesaki S, Bräuer-Hartmann D, Issa H, Bhayadia R, Alejo-Valle O, Verboon L, Schmell AL, Laszig S, Regényi E, Schuschel K, Labuhn M, Ng M, Winkler R, Ihling C, Sinz A, Glaß M, Hüttelmaier S, Matzk S, Schmid L, Strüwe FJ, Kadel SK, Reinhardt D, Yaspo ML, Heckl D, Klusmann JH RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia. Blood 2023, 141: 1105    
Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Müller I Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007, 110: 2197    
Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. American journal of clinical pathology 2013, 139: 345    
Ginsberg J, de Alava E, Ladanyi M, Wexler L, Kovar H, Paulussen M, Zoubek A, Jürgens H, Wunder J, Andrulis I, Malik R, Sorensen P, Womer R, Barr F EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol 1999, 17: 1809    
Ginzburg Y, Rivella S {beta}-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011, 118: 4321    
Giona F, Teofili L, Moleti ML, Martini M, Palumbo G, Amendola A, Mazzucconi MG, Testi AM, Pignoloni P, Orlando SM, Capodimonti S, Nanni M, Leone G, Larocca LM, Foà R Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome. Blood 2012; 119: 2219    
Giri N, Batista DL, Alter BP, Stratakis CA Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007, 92: 2624    
Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997, 70: 375    
Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF, walk-PHaSST Investigators and Patients Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PloS one 2014, 9:e99489    
Gleeson HK, Shalet SM The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocrine-related cancer 2004, 11: 589    
Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M, Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 2017, 129: 1548    
Gnekow A, Kaatsch P, Kortmann R, Wiestler OD HIT-LGG: Effektivität von Carboplatin-Vincristin bei progredienten Gliomen niedrigen Malignitätsgrades im Kindesalter - Zwischenbericht. Klin Pädiatr 2000, 212: 177    
Gnekow A Behandlung von Kindern und Jugendlichen mit Gliomen niedrigen Malignitätsgrades. Klinische Onkologie 2001, 372    
Gnekow A HIT-LGG. Aktuelle Neuropädiatrie 2001, 377    
Gnekow AK Therapie von Gliomen niedriger Malignität im Kindes- und Jugendalter. WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2003, 2: 8    
Gnekow AK, Packer RJ, Kortmann RD Astrocytic tumors, low-grade: general considerations, treatment considerations by primary site and tumor dissemination. In: Walker DA, Perilongo G, Punt JAG, Taylor RE (Eds) Brain and Spinal Tumors of Childhood Arnold publisher, London, 2004, V: 245 - 276    
Gnekow AK, Kortmann RD, Pietsch T, Emser A Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Klinische Padiatrie 2004, 216: 331    
Gnekow AK, Scheiderbauer J, Pietsch T, Soerensen N, Faldum A, Emser A, von Hornstein S, Warmuth-Metz M, Kuehl J HIT-LGG 1996-Success of a countrywide, comprehensive treatment strategy for children and adolescents with low grade glioma of all histologies and locations. Pedriatric Blood and Cancer 2005, 45: 465    
Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-oncology 2012, 14: 1265    
Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL, of the Low Grade Glioma Consortium and the participating centers A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report. European journal of cancer (Oxford, England : 1990) 2017, 81: 206    
Gnekow AK Gliome niedrigen Malignitätsgrades im Kindes- und Jugendalter. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2018    
Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL, Low Grade Glioma Consortium and the participating centers Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report". European journal of cancer 2018, 90: 156    
Gnekow AK, Kandels D, Tilburg CV, Azizi AA, Opocher E, Stokland T, Driever PH, Schouten-van Meeteren AYN, Thomale UW, Schuhmann MU, Czech T, Goodden JR, Warmuth-Metz M, Bison B, Avula S, Kortmann RD, Timmermann B, Pietsch T, Witt O SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma. Klinische Padiatrie 2019, 231: 107    
Gnekow AK, Kandels D, Tilburg CV, Azizi AA, Opocher E, Stokland T, Driever PH, Schouten-van Meeteren AYN, Thomale UW, Schuhmann MU, Czech T, Goodden JR, Warmuth-Metz M, Bison B, Avula S, Kortmann RD, Timmermann B, Pietsch T, Witt O Correction: SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma. Klinische Padiatrie 2019, 231:e2    
Gnekow AK, Kandels D, Pietsch T, Bison B, Warmuth-Metz M, Thomale UW, Kortmann RD, Timmermann B, Driever PH, Witt O, Schmidt R, Spix C Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome - Report from the German LGG Studies. Klinische Padiatrie 2021, 233: 107    
Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G Definition and prevalence of subfertility and infertility. Human reproduction (Oxford, England) 2005, 20: 1144    
Gobrecht O, Göbel U, Graubner U, Gutjahr P, Schock V, Spaar H, Janka-Schaub G Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study. Klin Pädiatr 1992, 204: 230    
Godzinski J, Moorman-Voestermans C, Sawicz-Birkowska K, Tournade M, Voute P, de Kraker J, Weirich A, Ludwig R, Gauthier F Paediatric surgical oncology. 5--Nephroblastoma. International Society of Paediatric Oncology (SIOP) Nephroblastoma Trial & Study Committee. Eur J Surg Oncol 1995, 21: 414    
Goddard AG, Kingston JE, Hungerford JL Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. The British journal of ophthalmology 1999, 83: 1320    
Godzinski J, Weirich A, Tournade M, Gauthier F, Buerger D, Moorman-Voestermans C, de Kraker J, Voute P, Ludwig R, Sawicz-Birkowska K, Vujanic G, Ducourtieux M Primary nephrectomy for emergency. Eur J Pediatr Surg 2001, 11: 36    
Göbel U, Kornhuber B, Schellong G, Winkler K Empfehlungen zur Struktur und Ausstattung Pädiatrisch-Onkologischer Zentren. Klin Pädiatr. 1991; 203    
Göbel U, Calaminus G, Harms D [Germ cell tumors in children and adolescents]. Praxis 1995 Sep 26; 84: 1063    
Göbel U, Calaminus G, Blohm M, Booss D, Felberbauer F, Hofmann U, Holschneider AM, Willnow U, Harms D Extracranial non-testicular teratoma in childhood and adolescence: introduction of a risk score for stratification of therapy. Klinische Padiatrie 1997, 209: 228    
Göring HD, Bork K, Späth PJ, Bauer R, Ziemer A, Hintner H, Wüthrich B Untersuchungen zum hereditären Angioödem im deutschsprachigen Raum. Hautarzt 1998, 49: 114–22    
Göbel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000, 11: 263    
Göbel U, Schneider DT, Calaminus G, Jürgens H, Spaar HJ, Sternschulte W, Waag K, Harms D Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001, 19: 1943    
Goemans BF, Zwaan CM, Martinelli S, Harrell P, de Lange D, Carta C, Reinhardt D, Hahlen K, Creutzig U, Tartaglia M, Heinrich MC, Kaspers GJ Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia. British journal of haematology 2005, 130: 801    
Goemans BF, Zwaan CM, Miller M, Zimmermann M, Harlow A, Meshinchi S, Loonen AH, Hahlen K, Reinhardt D, Creutzig U, Kaspers GJ, Heinrich MC Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia 2005, 19: 1536    
Goemans BF, Zwaan CM, Harlow A, Loonen AH, Gibson BE, Hahlen K, Reinhardt D, Creutzig U, Heinrich MC, Kaspers GJ In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets. Blood 2005, 106: 3532    
Göbel U, Calaminus G, Schneider DT, Koch S, Teske C, Harms D The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol. Klinische Padiatrie 2006, 218: 309    
Göhring G, Karow A, Steinemann D, Wilkens L, Lichter P, Zeidler C, Niemeyer C, Welte K, Schlegelberger B Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis? Annals of hematology 2007, 86: 733    
Goemans BF, Zwaan CM, Cloos J, de Lange D, Loonen AH, Reinhardt D, Hählen K, Gibson BE, Creutzig U, Kaspers GJ FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Leukemia research 2010,    
Göbel U, Schneider DT, Teske C, Schönberger S, Calaminus G Brain metastases in children and adolescents with extracranial germ cell tumor - data of the MAHO/MAKEI-registry. Klinische Padiatrie 2010, 222: 140    
Goedeke J, Haeberle B, Schmid I, von Schweinitz D 30. AFP Negative Cystic Liver Lesion in a Child Should Let One Think of Hepatoblastoma. J Pediatr Hematol Oncol 2011, 33:e245    
Göbel U, von Kries R, Teske C, Schneider DT, Beyerlein A, Bernbeck B, Calaminus G Brain metastases during follow-up of children and adolescents with extracranial malignant germ cell tumors: Risk adapted management decision tree analysis based on data of the MAHO/MAKEI-registry. Pediatric blood & cancer 2012, Epub ahead of print    
Göbel U, Calaminus G, Haas R, Teske C, Schönberger S, Schneider DT, Leuschner I, Harms D Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients. Klinische Padiatrie 2014, 226(6-7): 316    
Götte M, Taraks S, Boos J Sports in pediatric oncology: the role(s) of physical activity for children with cancer. Journal of pediatric hematology/oncology 2014, 36: 85    
Götte M, Kesting S, Taraks S, Boos J Rahmenbedingungen individualisierter stationärer Bewegungsförderung in der kinderonkologischen Akutversorgung. Bewegungstherapie und Gesundheitssport 2015, 31: 117    
Gödeke J, Luxenburger E, Trippel F, Becker K, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma. Hepatology international 2016, 10: 370    
Göhring G, Thomay K, Schmidt G, Ripperger T, Xu M, Wittner N, Chao MM, Baumann I, Niewisch M, Reinhardt D, Klingebiel T, Thol F, Schlegelberger B, Niemeyer CM A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl. Leukemia & lymphoma 2017, 58: 718    
Goebel AM, Gnekow AK, Kandels D, Witt O, Schmidt R, Hernáiz Driever P Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis. Journal of Cancer 2019, 10: 6314    
Götte M, Gauß G Kinder, Jugendliche und Krebs: Netzwerk ActiveOncoKids - Bewegungsförderung und Sporttherapie in der Kinderonkologie. Aktuelle Gesundheits-Nachrichten der Europäischen Akademie für Naturheilverfahren und Umweltmedizin 38, 2020, 34    
Gokarn N, Manwani D, Friedmann P, Borenstein SH, Jan D, Renaud E Outcomes after early splenectomy for hematological disorders. Journal of laparoendoscopic & advanced surgical techniques. Part A 2014, 24: 897    
Goldwein JW, Leahy JM, Packer RJ, Sutton LN, Curran WJ, Rorke LB, Schut L, Littman PS, D'Angio GJ Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 1990, 19: 1497    
Goldwein JW, Corn BW, Finlay JL, Packer RJ, Rorke LB, Schut L Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer 1991 Jun 1; 67: 2766    
Goldstein-Jackson SY, Gosheger G, Delling G, Berdel WE, Exner GU, Jundt G, Machatschek JN, Zoubek A, Jürgens H, Bielack SS, Cooperative Osteosarcoma Study Group COSS Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. Journal of cancer research and clinical oncology 2005, 131: 520    
Golan DE Hemolytic Anemias: redcell membrane and metabolic disorders. In: Goldman, L, Ausiele, D, eds,. Cecil medicine. 23rd. edt., Chap. 165 2007    
González-Murillo A, Lozano ML, Alvarez L, Jacome A, Almarza E, Navarro S, Segovia JC, Hanenberg H, Guenechea G, Bueren JA, Río P Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with fanconi anemia. Human gene therapy 2010, 21: 623    
Gooskens SL, Segers H, Pritchard-Jones K, Graf N, Dome JS, van den Heuvel-Eibrink MM, van den Heuvel-Eibrink MM The Clinical Relevance of Age at Presentation in Nephroblastoma. 2016,    
Gore L, Locatelli F, Zugmaier G, Handgretinger R, O'Brien MM, Bader P, Bhojwani D, Schlegel PG, Tuglus CA, von Stackelberg A Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Blood cancer journal 2018, 8: 80    
Goschzik T, Zur Mühlen A, Kristiansen G, Haberler C, Stefanits H, Friedrich C, von Hoff K, Rutkowski S, Pfister SM, Pietsch T Molecular stratification of medulloblastoma: Comparison of histological and genetic methods to detect Wnt activated tumors. Neuropathology and applied neurobiology 2014,    
Goschzik T, Gessi M, Dreschmann V, Gebhardt U, Wang L, Yamaguchi S, Wheeler DA, Lauriola L, Lau CC, Mueller HL, Pietsch T Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma. Journal of neuropathology and experimental neurology 2017, 76: 126    
Goschzik T, Mynarek M, Doerner E, Schenk A, Spier I, Warmuth-Metz M, Bison B, Obrecht D, Struve N, Kortmann RD, Schmid M, Aretz S, Rutkowski S, Pietsch T Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta neuropathologica 2022, 144: 1143    
Gottstein C, Schon G, Tawadros S, Kube D, Wargalla-Plate U, Hansmann M, Wacker H, Berthold F, Diehl V, Engert A Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model. Cancer Res 1994, 54: 6186    
Gottschling S, Längler A, Tautz C, Graf N Complementary and alternative medicine in pediatric oncology. Klinische Pädiatrie 2006, 218: 157    
Gotta J, Bielack S, Hecker-Nolting S, Sorg B, Kevric M, Salzmann-Manrique E, Klingebiel T When Your Ankle Becomes a Knee - Long-Term Functional Outcome and Quality of Life with a Rotationplasty after Resection of Malignant Limb Tumors. Klinische Padiatrie 2022, 234: 154    
Gotta J, Bochennek K, Klingebiel T, Bielack S, Wild PJ, Demes MC, Gradhand E Metachronous Osteosarcoma, A Differential Diagnosis to be Considered in Children With Osteosarcoma: A Review of Literature and a Case From Our Center. Journal of pediatric hematology/oncology 2023, 45: 105    
Goumnerova L Results of stereotactic radiosurgery in the management of recurrent ependymoma. Proceedings VIIth Annual Symposium Pediatric Neurooncology, Abstract 30 Washington 1996    
Gozzelino R, Arosio P Iron Homeostasis in Health and Disease. International journal of molecular sciences 2016 Jan 20; 17    
Graf N, Winkler K, Betlemovic M, Fuchs N, Bode U Methotrexate pharmacokinetics and prognosis in osteosarcoma. J Clin Oncol 1994, 12: 1443    
Graf N Wilms' tumor. Schweiz Rundsch Med Prax 1996, 85: 753    
Graf N, Weirich A Wilms' tumor - the State of the Art. Onkologie 1996, 19: 36    
Graf N, Weirich A, de Kraker J Staging problems in the pre-operative chemotherapy of Wilms' tumour. Br J Urol 1996, 78: 479    
Graf N Nephroblastom (Wilmstumor). Qualitätssicherung in der Onkologie: Diagnostische und therapeutische Standards in der Pädiatrischen Onkologie 1997    
Graf N Der Wilstumor - State of the art. Monatsschr Kinderheilkd 1999    
Graf N, Zoubek A, Niggli F, Weirich A, Aliani S, Bürger D, Harms D, Flentje M, Pötter R, Zieger B, Ludwig R Tumor volume and prognosis in patients with localized unilateral nephroblastoma treated preoperatively. Med Pediatr Oncol 1999, 33    
Graf N, Zoubek A, Weirich A, Ludwig R Erste Ergebnisse der Nephroblastomstudie SIOP 93-01/GPOH und Darstellung einer Nachfolgestudie. Monatsschr Kinderheilkd 1999    
Graubner U, Boos J, Creutzig U, Dörffel W, Lakomek M, Niemeyer C, Schrappe M, Spaar H, Belohradsky B Die antiinfektiöse Prophylaxe in der Pädiatrischen Onkologie. Klinische Pädiatrie 1999, 211    
Graf N, Tournade M, de Kraker J The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000, 27: 443    
Gray S, Eriksson T, Ekstrom C, Holm S, von Schweinitz D, Kogner P, Sandstedt B, Pietsch T, Ekstrom T Altered expression of members of the IGF-axis in hepatoblastomas. Br J Cancer 2000, 82: 1561    
Gray S, Eriksson T, Ekström C, Holm S, Schweinitz D, Kogner P, Sandstedt B, Pietsch T, Ekström T Decreased expression of insulin-like growth factor binding proteins 1 and 2 in hepatoblastomas; role of the IGF-axis components. British Journal of Cancer 2000, 82: 1561    
Grabenbauer GG, Schuchardt U, Buchfelder M, Rodel CM, Gusek G, Marx M, Doerr HG, Fahlbusch R, Huk WJ, Wenzel D, Sauer R Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol 2000, 54: 239-45.    
Graubner UB Antiviral prophylaxis. Klin Pädiatr 2001, 213 Suppl 1:A69    
Graubner UB, Liese J, Belohradsky BH Vaccination. Klin Pädiatr 2001 213 Suppl 1:A77    
Graf Einsiedel H, Taube T, Hartmann R, Wellmann S, Seifert G, Henze G, Seeger K Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia. Blood 2002, 99: 4629    
Graf N, Reinhard H Wilms tumors. Diagnosis and therapy. Urologe A 2003, 42:W391-W407    
Graf N, Semler O, Reinhard H Prognosis of Wilm's tumor in the course of the SIOP trials and studies. Urologe A 2004, 43: 421    
Graf N Osteosarkome. in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen Deutscher Ärzte-Verlag, 5. Aufl. 2004, 473    
Graf N, Rübe C, Gessler M Nierentumoren, in: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 847    
Graubner UB, Porzig S, Jorch N, Kolb R, Wessalowski R, Escherich G, Janka GE Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia. Pediatric blood & cancer 2008, 50: 259    
Grantzow R, Schmittenbecher P, Cremer H, Höger P, Rössler J, Hamm H, Hohenleutner U Hemangiomas in infancy and childhood. S 2k Guideline of the German Society of Dermatology with the working group Pediatric Dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine. Journal of the German Society of Dermatology 2008, 6: 324    
Grabow D, Spix C, Blettner M, Kaatsch P Strategy for long-term surveillance at the German Childhood Cancer Registry - an update. Klin padiatr 2011, 223: 159    
Grabow D, Lacher C, Kaatsch P Former childhood cancer patients need a competent help desk. Klin padiatr 2011, 223: 187    
Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S, Amson R, Telerman A, Nielsen P, Kohne E, Balser C, Heimpel H A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood 2011, 118: 6660    
Grace RF, Long M, Kalish LA, Neufeld EJ Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Pediatric blood & cancer 2012, 58: 216    
Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Pediatric blood & cancer 2012, 58: 221    
Graf N, Furtwaengler R Preoperative chemotherapy and local stage III in nephroblastoma. Translational Pediatrics 2014, 3    
Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet 2015, 386: 1649    
Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B Erythrocyte pyruvate kinase deficiency: 2015 status report. American journal of hematology 2015, 90: 825    
Graf N Nephroblastom (Wilms-Tumor). S1-Leitlinie 025/004 AWMF online 2016    
Grace RF, Barcellini W Management of pyruvate kinase deficiency in children and adults. Blood 2020, 136: 1241    
Grainger JD, Kühne T, Hippenmeyer J, Cooper N Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia. Annals of hematology 2021, Online ahead of print    
Graf N, Bergeron C, Brok J, de Camargo B, Chowdhury T, Furtwängler R, Gessler M, Godzinski J, Pritchard-Jones K, Ramirez-Villar GL, Rübe C, Sandstedt B, Schenk JP, Spreafico F, Sudour-Bonnange H, van Tinteren H, Verschuur A, Vujanic G, van den Heuvel-Eibrink MM Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP). Annals of oncology 2021, 32: 1327    
Graf M, Interlandi M, Moreno N, Holdhof D, Göbel C, Melcher V, Mertins J, Albert TK, Kastrati D, Alfert A, Holsten T, de Faria F, Meisterernst M, Rossig C, Warmuth-Metz M, Nowak J, Meyer Zu Hörste G, Mayère C, Nef S, Johann P, Frühwald MC, Dugas M, Schüller U, Kerl K Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors. Nature communications 2022, 13: 1544    
Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. Annals of hematology 2001, 80 Suppl 3:B73    
Greaves M Childhood leukaemia. BMJ 2002, 324: 283    
Greten TF, Manns MP, Reinisch I, Kaatsch P Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation. Gut 2005, 54: 732    
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jun 1; 27: 2677    
Greve T, Clasen-Linde E, Andersen MT, Andersen MK, Sørensen SD, Rosendahl M, Ralfkiaer E, Andersen CY Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood 2012, 120: 4311    
Gresele P, Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH 2015, 13: 314    
Grevener K, Haveman LM, Ranft A, van den Berg H, Jung S, Ladenstein R, Klco-Brosius S, Jürgens H, Merks JH, Dirksen U Management and Outcome of Ewing Sarcoma of the Head and Neck. Pediatric blood & cancer 2016, 63: 604    
Gresele P, Falcinelli E, Bury L Inherited platelet function disorders. Diagnostic approach and management. Hamostaseologie 2016, 36: 265    
Greinacher A, Pecci A, Kunishima S, Althaus K, Nurden P, Balduini CL, Bakchoul T Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. Journal of thrombosis and haemostasis : JTH 2017, 15: 1511    
Greimelmaier K, Calaminus G, Kristiansen G, Vokuhl C, Klapper W Chromosomal gains of 12p and 1q are not associated with inferior outcome of pediatric and adolescent germ cell tumors. Pediatric blood & cancer 2019, 66:e27777    
Greinix HT CAR-T-Zelltherapie: Nachbeobachtung der Patienten und CAR-T-Zell Register. Sperctrum Onkologie 2019, 06    
Grigull L, Beier R, Schrauder A, Kirschner P, Loening L, Jack T, Welte K, Sykora K, Schrappe M Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 2003, 46: 441    
Grimer R, Cannon S, Taminiau A, Bielack S, Kempf-Bielack B, Windhager R, Dominkus M, Saeter G, Bauer H, Meller I, Szendroi M, Folleras G, San Julian M, van der Eijken Osteosarcoma over the age of forty. Eur J Cancer 2003, 39: 157    
Grimbacher, B J. Schölmerich (Hrsg.): Medizinische Therapie in Klinik und Praxis. Springer Verlag 2003    
Grimer RJ, Bielack S, Flege S, Cannon SR, Foleras G, Andreeff I, Sokolov T, Taminiau A, Dominkus M, San-Julian M, Kollender Y, Gosheger G, European Musculo Skeletal Oncology Society Periosteal osteosarcoma--a European review of outcome. European journal of cancer (Oxford, England : 1990) 2005, 41: 2806    
Grois N, Flucher-Wolfram B, Heitger A, Mostbeck G, Hofmann J, Gadner H Diabetes insipidus in Langerhans cell histiocytosis. Med Pediatr Oncol 1995, 24: 248    
Grois N, Favara B, Mostbeck G, Prayer D Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998, 12: 287    
Groll A, Ritter J, Müller F Prevention of fungal infections in children and adolescents with cancer. Klinische Pädiatrie 2001, 213 Suppl 1:A50-A68    
Groll AH, Ritter J, Muller FM Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer. Klin Pädiatr 2001, 213 Suppl 1:A38    
Groll AH, Ritter J Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients. Klin Pädiatr 2005, 217 Suppl 1:S37    
van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P, Poulsen TS, den Boer ML, Horstmann M, Kamps WA, Veerman AJ, van Wering ER, van Noesel MM, Pieters R The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 2006, 91: 1212    
Grotzer MA, von Hoff K, von Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma. Klinische Padiatrie 2007, 219: 312    
Grotegut S, Kappler R, Tarimoradi S, Lehembre F, Christofori G, Von Schweinitz D Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. International journal of oncology 2010, 36: 1261    
Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Styczynski J, Warris A, Lehrnbecher T, on behalf of the Fourth European Conference on Infections in Leukaemia, a joint venture of the Infectious Diseases Working Party of the European Group for Blood Marrow Transplantation (EBMT-IDWP),the Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG),the International Immunocompromised Host Society (ICHS),the European Leukaemia Net (ELN) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. The lancet oncology 2014, 15:e327-e340    
Groebner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Huebschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, ICGC PedBrain-Seq Project,ICGC MMML-Seq Project,Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Fruehwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM The landscape of genomic alterations across childhood cancers. Nature 2018 Mar 15; 555: 321    
Groeneveld-Krentz S, Schroeder MP, Reiter M, Pogodzinski MJ, Pimentel-Gutierrez HJ, Vagkopoulou R, Hof J, Chen-Santel C, Nebral K, Bradtke J, Tuerkmen S, Baldus CD, Gattenloehner S, Haas OA, von Stackelberg A, Karawajew L, Eckert C, Kirschner-Schwabe R Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse. British journal of haematology 2019, 185: 266    
Groenendijk A, Spreafico F, de Krijger RR, Drost J, Brok J, Perotti D, van Tinteren H, Venkatramani R, Godziński J, Rübe C, Geller JI, Graf N, van den Heuvel-Eibrink MM, Mavinkurve-Groothuis AMC Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancers 2021, 13    
Groenendijk A, van Tinteren H, Jiang Y, de Krijger RR, Vujanic GM, Godzinski J, Rübe C, Schenk JP, Morosi C, Pritchard-Jones K, Al-Saadi R, Vaidya SJ, Verschuur AC, Ramírez-Villar GL, Graf N, de Camargo B, Drost J, Perotti D, van den Heuvel-Eibrink MM, Brok J, Spreafico F, Mavinkurve-Groothuis AMC Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols. European journal of cancer 2022, 163: 88    
Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D, Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. The lancet oncology 2007, 8: 696    
Grünewald TG, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S, Perot G, Jonker AH, Lucchesi C, Le Deley M, Oberlin O, Marec-Bérard P, Véron AS, Reynaud S, Lapouble E, Boeva V, Rio Frio T, Alonso J, Bhatia S, Pierron G, Cancel-Tassin G, Cussenot O, Cox DG, Morton LM, Machiela MJ, Chanock SJ, Charnay P, Delattre O Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat Genet 2015, 47: 1073    
Grunt S, Mazenauer L, Buerki SE, Boltshauser E, Mori AC, Datta AN, Fluss J, Mercati D, Keller E, Maier O, Poloni C, Ramelli GP, Schmitt-Mechelke T, Steinlin M Incidence and outcomes of symptomatic neonatal arterial ischemic stroke. Pediatrics 2015, 135:e1220    
Grueneberg I, Baust K, Calaminus G, Creutzig U Nachsorgeangebote online. Wir 2017, 1: 22    
Gruenewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E,Kovar H, Sorensen PH, Delattre O, Dirksen U Ewing sarcoma. Nature reviews. Disease primers 2018 Jul 5; 4: 5    
Grümme L, Biewald E, Reschke M, Fischhuber K, Hanbücken A, Schlüter S, Müller B, Kiefer T, Göricke S, Geismar D, Ryl T, Sirin S, Wieland R, Timmermann B, Lohmann D, Ebinger M, Brecht IB, Schönberger S, Schwab C, Eggert A, Süsskind D, Ritter-Sovinz P, Bechrakis NE, Ketteler P Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer 2022, 69:e29362    
Guardiola P, Socié G, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh J, Locatelli F, Souillet G, Cahn JY, Ljungman P, Miniero R, Shaw J, Vermylen C, Archimbaud E, Bekassy AN, Krivan G, Di Bartolomeo P, Bacigalupo A, Gluckman E Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998, 21 Suppl 2:S24    
Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JC, Ball SE, Locatelli F, Vermylen C, Skinner R, Ljungman P, Miniero R, Shaw PJ, Souillet G, Michallet M, Bekassy AN, Krivan G, Di Bartolomeo P, Heilmann C, Zanesco L, Cahn JY, Arcese W, Bacigalupo A, Gluckman E Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000, 95: 422    
Gualandro SF, Fonseca GH, Yokomizo IK, Gualandro DM, Suganuma LM Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality. British journal of haematology 2015, 125: 3401    
Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O, Deutschen Gesellschaft für Radioonkologie (DEGRO) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2014, 190: 26    
Guckenberger M, Andratschke N Stereotaktische Bestrahlung: Lokale Tumorkontrolle enorm verbessert. Dtsch Arztebl 2014, 111: [20]    
Guder WK, Hardes J, Nottrott M, Steffen AJ, Dirksen U, Streitbürger A Pelvic Ewing sarcoma: a retrospective outcome analysis of 104 patients who underwent pelvic tumor resection at a single supra-regional center. Journal of orthopaedic surgery and research 2020, 15: 534    
Guggemos A, Eckert C, Szczepanski T, Hanel C, Taube T, van der, Graf-Einsiedel H, Henze G, Seeger K Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia. haematologica 2003, 88: 736    
Gulden J Überlebende kindlicher Krebserkrankungen: Gebrechlich wie Senioren. Dtsch Arztebl 2014, 111: A-1860 / B-1593 / C    
Gunther P, Troger J, Graf N, Waag K, Schenk J MR volumetric analysis of the course of nephroblastomatosis under chemotherapy in childhood. Pediatr Radiol 2004, 34: 660    
Gururangan S, McLaughlin C, Quinn J, Rich J, Reardon D, Halperin EC, Herndon J, Fuchs H, George T, Provenzale J, Watral M, McLendon RE, Friedman A, Friedman HS, Kurtzberg J, Vredenbergh J, Martin PL High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 2003, 21: 2187    
Gutjahr P Krebs? Mein Kind? Leukämie und bösartige Tumoren bei Kindern. S. Hirzel Verlag Stuttgart - Leipzig 2000, 53    
Gutjahr P Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004    
Gutjahr P Tumoren des Zentralnervensystems, in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 373    
Gutjahr P Retinoblastome, in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 499    
Göbel U, Bamberg M, Calaminus G, Gnekow A, Herrmann H, Lenard H, Spaar H, Niethammer D, Kühl J, Harms D Improved prognosis of intracranial germ cell tumors by intensified therapy. Klin Pädiatr 1993, 205: 217    
Göbel U, Calaminus G, Teske C, Bamberg M, Bokkerink J, Haas R, Holschneider A, Janka-Schaub G, Jürgens H, Mittler U BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89. Klin Pädiatr 1993, 205: 231    
Göbel U, Calaminus G, Harms D Ovarielle Keimzelltumoren bei Kindern und Jugendlichen:Ergebnisse der Studien MAKEI 1983/86 und 89 der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). GPOH 1995, 23    
Göbel U Teratome und andere Keimzelltumoren. Therapie der Krankheiten im Kindes- und Jugendalter 1997, 507    
Göbel U, Calaminus G, Haas H Keimzelltumoren. Diagnostische und therapeutische Standards in der Pädiatrischen Onkologie 1997, 69    
Göbel U, Calaminus G, Haas H Keimzelltumoren im Kindesalter, in Schmoll, H.-J, Höffken, K, Possinger, K. (Hrsg.). Kompendium internistischer Onkologie, Berlin, Springer 1997, 2    
Göbel U, Calaminus G, Haas R Keimzelltumoren. Uroonkologie 1997, 598    
Göbel U, Calaminus G, Engert J, Kaatsch P, Gadner H, Bokkerink J, Hass R, Waag K, Blohm M, Dippert S, Teske C, Harms D Teratomas in infancy and childhood. Med Pediatr Oncol 1998, 31: 8    
Göbel U, Calaminus G, Waag K, Jonat W, Harms D Extracranial non-testicular teratoma in childhood and adolescents-the German experience. Germ Cell Tumors 1998,IV: 233    
Göbel U, Calaminus G, Haas R Keimzelltumoren im Kindesalter (Solide Tumoren im Kindesalter). Kompendium internistischer Onkologie In Schmoll, H -J , Höffken,K , Possinger,K (eds), Berlin, Springer 1999, 2    
Göbel U, Schneider D, Calaminus G, Harms D Tumoren im Kindesalter. Maligne Keimzelltumoren. Onkologie systematisch (Diagnostik und interdisziplinäre Therapie maligner Tumoren) 1999, 396    
Göbel U, Calaminus G, Bamberg M, Engert J, Haas H, Jonat W, Kortmann R, Schneider D, Harms D Keimzelltumoren bei Kindern und Jugendlichen. Der Onkologe 2000, 6    
Göbel U, Calaminus G, Engert J, Haas R, Jonat W, Harms D Malignant extracranial non-testicular germ cell tumors (GCTs)-the German experience. Germ Cell Tumors 2000,IV: 205    
Göbel U, Schneider D, Calaminus G, Haas R, Schmidt P, Harms D Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 2000, 11: 263    
Göbel U, Schneider D, Calaminus G, Jürgens H, Spaar H, Sternschulte W, Waag K, Harms D Multimodal treatment of malignant sacrococcygeal germ cell tumors. J Clin Oncol 2001, 19: 1943    
232 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.